While no widely publicized class action lawsuit specifically titled “Aetna Prior Authorization Delay Class Action” currently exists as a major settlement, the topic addresses a critical problem facing millions of insured Americans: delays in prior authorization that prevent timely access to medically necessary care. Prior authorization is the process where insurance companies require doctors to get pre-approval before providing certain treatments, prescriptions, or procedures. When these approvals are delayed, patients often face treatment postponements, health deterioration, and financial hardship—even when they ultimately qualify for coverage. The real-world impact is significant.
Consider a patient whose oncologist prescribes proton beam therapy for prostate cancer, but Aetna delays or denies the prior authorization without adequate clinical review. This isn’t hypothetical: Aetna settled a $3.42 million class action in 2024 for wrongfully denying proton beam therapy claims for prostate cancer patients between January 2015 and March 2024. That settlement involved thousands of patients who experienced treatment delays while fighting both their disease and their insurance company. Although prior authorization delays haven’t generated a single unified class action against Aetna, the company has faced multiple settlements related to improper claim denials, authorization practices, and failure to process requests timely. Understanding these cases, Aetna’s current practices, and your rights as an insured is essential if you’ve experienced similar denials.
Table of Contents
- Why Prior Authorization Delays Continue Despite Industry Reforms
- Aetna’s Prior Authorization Practices and Settlement History
- Related Class Action Settlements and What They Reveal
- How to File a Claim or Challenge a Prior Authorization Denial
- Prior Authorization Denials for Other Conditions and Services
- Industry-Wide Pledges and Current Standards
- What Changed and What Remains Unresolved
- Conclusion
Why Prior Authorization Delays Continue Despite Industry Reforms
Prior authorization requirements exist ostensibly to prevent unnecessary or inappropriate care, but the system routinely creates dangerous delays that contradict that purpose. Studies show that authorization requests that should take hours sometimes stretch into weeks, leaving patients in limbo about whether they’ll receive approved treatments. Insurance companies like Aetna process thousands of authorization requests daily; the sheer volume, combined with understaffing and outdated systems, means some requests get lost or delayed indefinitely. Aetna’s scale makes this problem acute. As one of the nation’s largest insurers, Aetna manages prior authorizations for millions of patients across commercial plans, Medicare Advantage, and Medicaid programs.
In 2025, over 60 major insurers including Aetna pledged to streamline prior authorization processes, committing to reduce procedures requiring prior authorization altogether and honor approvals for 90 days when patients switch plans. However, pledges and actual practice don’t always align. A patient scheduled for surgery next week cannot wait for industry reforms—they need a yes-or-no answer now. The danger compounds when prior authorization delays affect urgent or semi-urgent care. A patient waiting for approval of a specialist referral, imaging study, or infusion therapy faces real health consequences if that approval drags on for 10 days instead of 24 hours. Even when the authorization ultimately comes through, the delay has often already caused harm: the patient’s condition worsened, the treatment window closed, or the patient deferred care out of frustration and cost concerns.
Aetna’s Prior Authorization Practices and Settlement History
As of April 2026, Aetna has made public commitments to improve prior authorization processing. The company reports that 88% of prior authorizations are now standardized (meaning they follow clear criteria rather than case-by-case review), and 95% of eligible prior authorizations are approved within 24 hours. Additionally, Aetna claims 83% of eligible authorizations are processed in real time, and the company maintains that it requires prior authorization for fewer medical services than any other national health plan. These statistics, if accurate, suggest progress. However, statistics mask individual failures. A patient whose authorization takes three weeks instead of 24 hours doesn’t care about the 95% average—they experienced the exception.
Moreover, these figures come from Aetna itself, not independent audits. There’s a distinction between approving an authorization within 24 hours versus actually communicating that approval to the patient and their doctor, and between “standardized” processes and processes that still include clinical errors. Aetna’s settlement history reveals a pattern of problematic authorizations practices. The $3.42 million proton beam therapy settlement (concluded in 2024) compensated patients whose claims for proton beam therapy for prostate cancer were wrongfully denied between January 2015 and March 2024. This wasn’t a case of delayed approvals alone; it involved outright denials of a treatment that clinical guidelines support. The settlement suggests Aetna’s medical reviewers were applying overly restrictive criteria or failing to properly evaluate clinical evidence. Additionally, in March 2026, Aetna agreed to pay $117.7 million to resolve false Claims Act allegations that the company used inaccurate diagnosis codes for Medicare Advantage plans (2018–2023), affecting benefit eligibility and prior authorization decisions.
Related Class Action Settlements and What They Reveal
The $3.42 million proton beam therapy settlement is the most directly relevant to prior authorization and coverage denial issues. In that case, eligible patients received compensation for wrongful denials. The settlement required Aetna to establish a claims-filing process for patients to submit documentation, medical records, and proof of injury. Eligible claimants typically received damages ranging from several hundred to several thousand dollars, depending on the extent of harm (treatment delay, out-of-pocket costs, health impact). The $117.7 million Medicare Advantage settlement, while broader in scope, also touches on authorization and eligibility issues. That settlement addressed how Aetna coded diagnoses for Medicare Advantage members, which directly affects which services require prior authorization and which qualify for coverage.
If Aetna miscoded diagnoses systematically, patients may have experienced improper denials or authorizations based on inaccurate medical records. The settlement required restitution to affected beneficiaries and mandated corrective compliance measures. Neither settlement is a class action lawsuit still ongoing—both are resolved. However, they establish that Aetna’s authorization and claims practices have faced significant legal scrutiny. If you experienced a wrongful prior authorization denial during the relevant time periods (proton beam therapy claims from January 2015–March 2024, or Medicare Advantage coverage issues from 2018–2023), you may still have rights to file a claim under these settlements. Settlement claim deadlines vary; some have already passed, while others may remain open. This is why reviewing your own claim history is urgent.
How to File a Claim or Challenge a Prior Authorization Denial
If Aetna has delayed or denied a prior authorization for your care, your first step should be to appeal the decision directly to Aetna. Most health plans, including Aetna, are required by law to have internal appeals processes. When you appeal, submit any additional clinical evidence, medical records, or physician statements that support the medical necessity of the requested treatment. Many initial denials are reversed on appeal, especially if the original decision contained incomplete medical information. If your appeal is denied and you believe the denial is wrongful, you have additional options. First, check whether your claim falls within the scope of any Aetna settlement.
If Aetna denied your proton beam therapy claim for prostate cancer between January 2015 and March 2024, you may be eligible for compensation under that settlement without filing a lawsuit. Similarly, if you believe diagnosis-coding errors affected your Medicare Advantage coverage between 2018 and 2023, you may have claim rights. Most settlement claims require documentation of your Aetna membership, your claim denial, and medical records proving the claim should have been approved. Second, consult an attorney or patient advocacy organization specializing in insurance denials. Some offer free or low-cost consultations. An attorney can assess whether your case qualifies for a class action (which would require a larger group of similarly situated patients), a private lawsuit, or settlement claim eligibility. This step is important because filing deadlines exist—you cannot challenge a denial indefinitely, and many settlement claim windows are time-limited.
Prior Authorization Denials for Other Conditions and Services
Prior authorization denials aren’t limited to proton beam therapy or one medical condition. Aetna’s members have reported authorization delays or denials for specialty medications, advanced imaging (MRI, PET scans), orthopedic procedures, mental health services, and many other treatments. Each denial carries its own consequences. A patient denied authorization for a specialty drug for rheumatoid arthritis may face inflammatory flare-ups while appealing. A patient denied advanced imaging for suspected cancer may experience diagnostic delay that worsens prognosis. A major limitation of current prior authorization reform efforts, including Aetna’s stated improvements, is that they don’t address the underlying problem: insurance companies have financial incentives to deny or delay authorizations.
Even with 24-hour processing standards, if an insurer denies authorization incorrectly on day one, a 24-hour decision is meaningless—the patient still faces delay and the burden of appeal. Furthermore, “standardized” criteria can still be applied too restrictively. If Aetna’s standard for approving a certain treatment is narrower than clinical guidelines, eligible patients will still be denied. Another warning: prior authorization requirements in Medicare Advantage plans differ from those in commercial plans. Your Aetna Medicare Advantage plan may require prior authorization for services your commercial Aetna plan would cover without pre-approval. Additionally, Aetna’s in-network and out-of-network prior authorization requirements differ. When changing plans or providers, verify the authorization requirements for your specific plan before assuming coverage.
Industry-Wide Pledges and Current Standards
In June 2025, over 60 major insurers including Aetna made a public commitment to improve prior authorization. The pledges included: reducing the number of procedures requiring prior authorization, honoring prior authorizations for 90 days when patients switch plans (so patients don’t lose approval mid-treatment), and clearly communicating denial reasons to patients and physicians. These commitments, set to be implemented by January 1, 2026, represent a recognition that the status quo is unsustainable.
However, pledges aren’t enforcement mechanisms. As of May 2026, it remains unclear how thoroughly insurers including Aetna have implemented these commitments, and complaints about prior authorization delays continue. If you’re evaluating Aetna as an insurance option, ask specifically about their prior authorization turnaround times, which procedures require authorization, and their appeals process. Comparing Aetna’s authorization requirements to competing plans may reveal significant differences in administrative burden and access to care.
What Changed and What Remains Unresolved
Aetna’s public statements (April 2026) indicate the company has made technical improvements: 83% of eligible prior authorizations are now processed in real time, and 88% are standardized. These improvements likely reflect investment in automation and system modernization. If these claims are accurate, Aetna is performing better than it was five to ten years ago when the proton beam therapy denials and Medicare Advantage coding errors were occurring.
Yet “improved” doesn’t mean “perfect.” Patients continue to experience prior authorization delays, denials, and confusion about coverage. The insurance industry’s fundamental business model—where insurers profit by approving fewer claims and paying less—creates ongoing tension with patient care needs. Future improvements will likely come through continued regulatory pressure, litigation (including class actions when systemic problems emerge), and competition among insurers offering better authorization practices. For now, patients must remain vigilant: track your authorization requests, appeal denials, and seek help if you believe a denial is wrongful.
Conclusion
While no single massive class action titled “Aetna Prior Authorization Delay Class Action” defines the landscape, Aetna has settled multiple significant claims related to improper authorizations, wrongful denials, and claim mishandling. The $3.42 million proton beam therapy settlement and the $117.7 million Medicare Advantage settlement both demonstrate that Aetna’s practices have faced legal accountability. If you’ve experienced a wrongful prior authorization delay or denial from Aetna, you may have options: appealing the decision, filing a claim under an existing settlement, or pursuing legal action with an attorney’s help.
The broader lesson is that prior authorization remains a common pain point in American healthcare, and while the industry has made pledges to improve, individual patients must advocate for themselves. Document all authorization requests and denials, appeal unfavorable decisions, understand your rights, and seek professional help if a denial appears unjustified. If you believe you’re part of a larger group experiencing similar problems with Aetna, consult an attorney—that’s how class actions form and progress happens.